Vertex Pharmaceuticals (VRTX) Gains from Investment Securities (2015 - 2024)
Vertex Pharmaceuticals (VRTX) posted Gains from Investment Securities of -$1.2 million for Q4 2024, down 500.0% on a QoQ basis from $300000.0 in Q3 2024, and up 97.61% year-over-year from -$607243.5 in Q1 2024.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Gains from Investment Securities (2015 - 2024) Analysis & Trends
Vertex Pharmaceuticals has reported Gains from Investment Securities for 9 years, with the latest figure at -$1.2 million in Q4 2024.
- On a quarterly basis, Gains from Investment Securities rose 97.61% year-over-year to -$1.2 million in Q4 2024; TTM through Dec 2024 was -$500000.0, a 99.03% increase from a year earlier, with the FY2024 full-year figure at -$500000.0, up 99.03% from the prior year.
- Gains from Investment Securities was -$1.2 million for Q4 2024 at Vertex Pharmaceuticals, down from $300000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $9.2 million in Q2 2020, with the low at -$50.3 million in Q4 2023.
- Average Gains from Investment Securities over 5 years is -$5.0 million, with a median of $100000.0 recorded in 2024.
- The largest YoY upside for Gains from Investment Securities was 190.0% in 2022 against a maximum downside of 3175.0% in 2022.
- Over 5 years, Gains from Investment Securities stood at $500000.0 in 2020, then tumbled by 500.0% to -$2.0 million in 2021, then jumped by 190.0% to $1.8 million in 2022, then tumbled by 2894.44% to -$50.3 million in 2023, then soared by 97.61% to -$1.2 million in 2024.
- The last three Gains from Investment Securities figures came in at -$1.2 million (Q4 2024), $300000.0 (Q3 2024), and $500000.0 (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -50.30 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | -600,000.00 |
| Mar 31, 2023 | -1.90 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | -2.60 Mn |
| Jun 30, 2022 | -49.20 Mn |
| Mar 31, 2022 | -7.50 Mn |
| Dec 31, 2021 | -2.00 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 1.60 Mn |
| Mar 31, 2021 | -3.90 Mn |
| Dec 31, 2020 | 500,000.00 |
| Sep 30, 2020 | 1.80 Mn |
| Jun 30, 2020 | 9.20 Mn |
| Mar 31, 2020 | 1.60 Mn |
API Access
Vertex Pharmaceuticals Gains from Investment Securities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-investment-securities", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();